Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study. (Q50302127)
Jump to navigation
Jump to search
scientific article published in February 1998
Language | Label | Description | Also known as |
---|---|---|---|
English | Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study. |
scientific article published in February 1998 |
Statements
Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study (English)
J K Buitelaar
R J van der Gaag
J van der Hoeven
1 February 1998